Vogt-Koyanagi-Harada Syndrome following COVID-19 and ChAdOx1 nCoV-19 (AZD1222) vaccine.

Autor: Saraceno JJF; Department of Ophthalmology, Hospital Sao Rafael, Salvador, Brazil., Souza GM; Department of Ophthalmology and Visual Science, Federal University of Sao Paulo, Sao Paulo, Brazil., Dos Santos Finamor LP; Department of Ophthalmology and Visual Science, Federal University of Sao Paulo, Sao Paulo, Brazil., Nascimento HM; Department of Ophthalmology and Visual Science, Federal University of Sao Paulo, Sao Paulo, Brazil. helomn@gmail.com.; Research Department, Instituto Paulista de Estudos e Pesquisas em Oftalmologia/Instituto da Visão (IPEPO), Sao Paulo, Brazil. helomn@gmail.com., Belfort R Jr; Department of Ophthalmology and Visual Science, Federal University of Sao Paulo, Sao Paulo, Brazil.; Research Department, Instituto Paulista de Estudos e Pesquisas em Oftalmologia/Instituto da Visão (IPEPO), Sao Paulo, Brazil.
Jazyk: angličtina
Zdroj: International journal of retina and vitreous [Int J Retina Vitreous] 2021 Aug 30; Vol. 7 (1), pp. 49. Date of Electronic Publication: 2021 Aug 30.
DOI: 10.1186/s40942-021-00319-3
Abstrakt: The challenge of COVID-19 has rapidly changed medical management worldwide. The relatively small time from pandemic to vaccines regulatory approval triggered a race toward vaccines development. However, important questions regarding SARS-CoV-2 vaccines remain. A case of complete Vogt-Koyanagi-Harada (VKH) Syndrome that occurred 4 days following SARS-CoV-2 vaccination and another patient that developed VKH 14 days post COVID-19 clinical onset are presented. A causal relationship between COVID-19 and uveitis may exist.
(© 2021. The Author(s).)
Databáze: MEDLINE
Externí odkaz: